First Horizon Corporation (FHN) concluded trading on Wednesday at a closing price of $18.08, with 5.01 million shares of worth about $90.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.79% during that period and on April 30, 2025 the price saw a loss of about -0.39%. Currently the company’s common shares owned by public are about 507.00M shares, out of which, 500.26M shares are available for trading.
Stock saw a price change of 3.97% in past 5 days and over the past one month there was a price change of -6.90%. Year-to-date (YTD), FHN shares are showing a performance of -10.23% which increased to 22.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $14.09 but also hit the highest price of $22.44 during that period. The average intraday trading volume for First Horizon Corporation shares is 6.42 million. The stock is currently trading 3.88% above its 20-day simple moving average (SMA20), while that difference is down -3.82% for SMA50 and it goes to -1.75% lower than SMA200.
First Horizon Corporation (NYSE: FHN) currently have 507.00M outstanding shares and institutions hold larger chunk of about 87.74% of that.
The stock has a current market capitalization of $9.17B and its 3Y-monthly beta is at 0.60. PE ratio of stock for trailing 12 months is 12.59, while it has posted earnings per share of $1.44 in the same period. Its PEG reads 1.19 while making debt-to-equity ratio of 0.63. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FHN, volatility over the week remained 2.61% while standing at 5.31% over the month.
Stock’s fiscal year EPS is expected to rise by 9.35% while it is estimated to increase by 10.19% in next year. EPS is likely to grow at an annualized rate of 10.62% for next 5-years, compared to annual growth of -0.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on April 07, 2025 offering an Outperform rating for the stock and assigned a target price of $22 to it. On September 24, 2024, Wedbush Downgrade their recommendations, while on July 18, 2024, Raymond James Downgrade their ratings for the stock with a price target of $18. Stock get a Mkt perform rating from Keefe Bruyette on July 17, 2024.
